New protein-based nanodrugs for the development of targeted tumor-agnostic therapy

Project Details

StatusActive
Effective start/end date20/02/2219/02/25

Collaborative partners

  • Universitat Autònoma de Barcelona (UAB)
  • Nanoligent, S.L. (lead)
  • Sant Pau Institute for Biomedical Research (IIB Sant Pau)